Debasish Maiti1, Zhenhua Xu, Elia J Duh. 1. Department of Ophthalmology, Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA.
Abstract
PURPOSE: Vascular endothelial growth factor is a key regulator of physiological and pathologic angiogenesis. Although much is known about the major upstream signaling pathways of VEGF in endothelial cells, less is known about key transcription factors involved in VEGF action. The transcription factor myocyte enhancer factor (MEF)-2C is thought to play an important role in vasculogenesis and angiogenesis during vascular development. The purpose of this study was to investigate the regulation of MEF2C expression and MEF2-dependent activity in endothelial cells by VEGF. METHODS: Expression of MEF2C in human retinal endothelial cells and human umbilical vein endothelial cells was assayed by real-time PCR and Western blot. VEGF regulation of MEF2-dependent transcription was studied using an MEF2-luciferase reporter construct containing three copies of a high-affinity MEF2 binding site. The effect of MEF2 on endothelial cell migration was evaluated using a dominant-negative MEF2C mutant. RESULTS: VEGF induced MEF2C expression in a dose- and time-dependent fashion. This induction was completely abrogated by the inhibition of protein kinase C and was partially blocked by the inhibition of PKC-beta and PKC-delta. In addition to regulating MEF2C expression, VEGF stimulated transcription from an MEF2-dependent promoter. VEGF stimulation of transcription was significantly reduced by the inhibition of calcineurin, CaMKII, p38 MAPK, and PKC, but not by the inhibition of ERK1/2 or BMK1/ERK5. Transfection of a dominant-negative mutant of MEF2C significantly inhibited VEGF-stimulated endothelial cell migration. CONCLUSIONS: These results implicate VEGF as a key regulator of MEF2C and suggest that MEF2 may be an important mediator of VEGF in endothelial cells.
PURPOSE:Vascular endothelial growth factor is a key regulator of physiological and pathologic angiogenesis. Although much is known about the major upstream signaling pathways of VEGF in endothelial cells, less is known about key transcription factors involved in VEGF action. The transcription factor myocyte enhancer factor (MEF)-2C is thought to play an important role in vasculogenesis and angiogenesis during vascular development. The purpose of this study was to investigate the regulation of MEF2C expression and MEF2-dependent activity in endothelial cells by VEGF. METHODS: Expression of MEF2C in human retinal endothelial cells and human umbilical vein endothelial cells was assayed by real-time PCR and Western blot. VEGF regulation of MEF2-dependent transcription was studied using an MEF2-luciferase reporter construct containing three copies of a high-affinity MEF2 binding site. The effect of MEF2 on endothelial cell migration was evaluated using a dominant-negative MEF2C mutant. RESULTS:VEGF induced MEF2C expression in a dose- and time-dependent fashion. This induction was completely abrogated by the inhibition of protein kinase C and was partially blocked by the inhibition of PKC-beta and PKC-delta. In addition to regulating MEF2C expression, VEGF stimulated transcription from an MEF2-dependent promoter. VEGF stimulation of transcription was significantly reduced by the inhibition of calcineurin, CaMKII, p38MAPK, and PKC, but not by the inhibition of ERK1/2 or BMK1/ERK5. Transfection of a dominant-negative mutant of MEF2C significantly inhibited VEGF-stimulated endothelial cell migration. CONCLUSIONS: These results implicate VEGF as a key regulator of MEF2C and suggest that MEF2 may be an important mediator of VEGF in endothelial cells.
Authors: Kelvin J A Davies; Gennady Ermak; Beverley A Rothermel; Melanie Pritchard; Joseph Heitman; Joohong Ahnn; Flavio Henrique-Silva; Dana Crawford; Silvia Canaider; Pierluigi Strippoli; Paolo Carinci; Kyung-Tai Min; Deborah S Fox; Kyle W Cunningham; Rhonda Bassel-Duby; Eric N Olson; Zhuohua Zhang; R Sanders Williams; Hans-Peter Gerber; Mercè Pérez-Riba; Hisao Seo; Xia Cao; Claude B Klee; Juan Miguel Redondo; Lois J Maltais; Elspeth A Bruford; Sue Povey; Jeffery D Molkentin; Frank D McKeon; Elia J Duh; Gerald R Crabtree; Martha S Cyert; Susana de la Luna; Xavier Estivill Journal: FASEB J Date: 2007-06-26 Impact factor: 5.191
Authors: Thomas S Scerri; Anna Quaglieri; Carolyn Cai; Jana Zernant; Nori Matsunami; Lisa Baird; Lea Scheppke; Roberto Bonelli; Lawrence A Yannuzzi; Martin Friedlander; Catherine A Egan; Marcus Fruttiger; Mark Leppert; Rando Allikmets; Melanie Bahlo Journal: Nat Genet Date: 2017-02-27 Impact factor: 38.330
Authors: Andrea L Frump; Sébastien Bonnet; Vinicio A de Jesus Perez; Tim Lahm Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-11-02 Impact factor: 5.464
Authors: Garyfallia Papaioannou; Fatemeh Mirzamohammadi; Thomas S Lisse; Shigeki Nishimori; Marc N Wein; Tatsuya Kobayashi Journal: J Bone Miner Res Date: 2015-06 Impact factor: 6.741
Authors: Stefan C Materna; Tanvi Sinha; Ralston M Barnes; Kelly Lammerts van Bueren; Brian L Black Journal: Dev Biol Date: 2018-12-03 Impact factor: 3.582
Authors: Anna Csiszar; Danuta Sosnowska; Zsuzsanna Tucsek; Tripti Gautam; Peter Toth; Gyorgy Losonczy; Ricki J Colman; Richard Weindruch; Rozalyn M Anderson; William E Sonntag; Zoltan Ungvari Journal: J Gerontol A Biol Sci Med Sci Date: 2012-08-17 Impact factor: 6.053